chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Constant explosive diarrhea, pain in lower abdominal pain. Dr script for dicyclomine - nothing changed. Dr ordered that I remove dairy from my diet. I did nothing changed. Still not eating or drinking dairy products.
Modern a covid-19 vaccine  Headache. Body aches. Tiredness. Chills.
the vaccines was expired on 9/22/2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 25-year-old male patient who received HAB (Twinrix) (batch number 2KE55, expiry date 22-SEP-2023) for prophylaxis.   On 30-OCT-2023, the patient received the 1st dose of Twinrix. On 30-OCT-2023, an unknown time after receiving Twinrix, the patient experienced expired vaccine used (Verbatim: the vaccines was expired on 9/22/2023). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 30-OCT-2023 The pharmacist reported that a male patient received Twinrix 1st dose today on the standar schedule, but she did not realized that the vaccines was expired on 22nd September 2023, which led expired vaccine used. The reporter consented to follow up.
Patient presented to Urgent Care on 6/2/2021 with 3 week history of right lower quadrant abdominal pain. Patient was transferred to Emergency Department for rule out of appendicitis. In Emergency Room, patient had a CT performed that showed a "large non-occlusive thrombus filling significant potion of the inferior vena cava." Patient was admitted to the hospital (6/2/2021) and discharged home on 6/5/2021. Patient is now on anticoagulant: Xarelto.  Pt now having palpitations and lightheadedness for which she has a follow up appointment with her Primary Care Doctor today (6/9/2021).
Tuesday received shots. Wednesday, Mom noticed small red bump(s) on right arm, spread to left arm on Thursday and on to face and right arm by Friday. No Bumps on chest or legs, 1 small red bump on left side of back. A few bumps on right arm - small, red with small amount of crusting/weeping.
begun to feel dizzy and very light-headed/Dizziness; weak; had been falling a lot as well; Loss of balance; Can Barely Walk/Can't get around because it hurts so bad; Extreme Muscle Weakness; "Out of Sorts"; Delayed receiving second dose because he "bumped his elbow"; bursitis; bumped his elbow; This spontaneous case was reported by a patient family member or friend and describes the occurrence of DIZZINESS (begun to feel dizzy and very light-headed/Dizziness), ASTHENIA (weak), FALL (had been falling a lot as well), BALANCE DISORDER (Loss of balance) and GAIT DISTURBANCE (Can Barely Walk/Can't get around because it hurts so bad) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (begun to feel dizzy and very light-headed/Dizziness), ASTHENIA (weak), FALL (had been falling a lot as well), BALANCE DISORDER (Loss of balance), GAIT DISTURBANCE (Can Barely Walk/Can't get around because it hurts so bad), MUSCULAR WEAKNESS (Extreme Muscle Weakness), FEELING ABNORMAL ("Out of Sorts"), INTENTIONAL PRODUCT USE ISSUE (Delayed receiving second dose because he "bumped his elbow"), BURSITIS (bursitis) and JOINT INJURY (bumped his elbow). The patient was treated with PREDNISOLONE for Bursitis, at an unspecified dose and frequency. At the time of the report, DIZZINESS (begun to feel dizzy and very light-headed/Dizziness), ASTHENIA (weak), FALL (had been falling a lot as well), BALANCE DISORDER (Loss of balance), GAIT DISTURBANCE (Can Barely Walk/Can't get around because it hurts so bad), MUSCULAR WEAKNESS (Extreme Muscle Weakness), FEELING ABNORMAL ("Out of Sorts"), INTENTIONAL PRODUCT USE ISSUE (Delayed receiving second dose because he "bumped his elbow"), BURSITIS (bursitis) and JOINT INJURY (bumped his elbow) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.  It was reported that caller is returning call from safety to provide email address.    This case was linked to MOD-2021-231221 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Treatment medication are added and New events are added. On 16-Jul-2021: Follow up document received contains No significant information (NNI).
I had no reaction to vaccine. On 11/27/2022, I began not feeling well with a fever and cough. On 12/01/2022, I went to a clinic to be tested for COVID-19 and it was positive. I did not receive a prescription but advised to take guaifenesin. I finally tested COVID-19 negative on 12/15/2022. As of today, I am very confused and very weak. I rarely get sick and when I do, I get very sick.
This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received PREVNAR 13, (lot number and expiration date unknown) via an unspecified route of administration on an unspecified date at a single dose for immunization. Medical history included ongoing gluten allergy. The patient's concomitant medications were not reported. On an unspecified date, the patient wanted to know if there are sulfates in pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) formulation as she has a gluten allergy. The patient stated that she had already been vaccinated with the vaccine and since then she has experienced itching all over her body stating legs, arms, back, face and that the itching has woken her up and 3 AM. The outcome of the events was unknown. The following information on the batch number has been requested.
I95.9 HYPOTENSION 12/7/2022 ATRIAL FIBRILLATION, PERMANENT I95.9 HYPOTENSION 12/7/2022 AICD BATTERY REPLACEMENT I95.9 HYPOTENSION 12/7/2022 HYPOTENSION I95.9 HYPOTENSION 12/7/2022 SYSTOLIC HEART FAILURE, ACUTE ON CHRONIC I95.9 HYPOTENSION 12/7/2022 SYNCOPE
Inadvertantly gave the Bivalent Covid vaccine instead of the monovalent Covid vaccine.  There was no "adverse" event.  No signs/symptoms.
patient was being seen on 9/28/20 for a rash that developed on 9/23/20 following IMZs (Shingrix and Fluzone HD) administered on 9/16/20. Patient had recalled rash was on right side and suggested topical cream (VAGISIL for itching and pain) for some relief while patient was waiting to be seen on Monday by provider to double check rash. Pharmacist did not recall prior vaccines when patient asked for recommendation on Saturday 9/26/20.  Patient  was waiting til Monday because did not feel an ER trip was necessary. Provider gave patient Valtrex and Prednisone for treatment on 9/28/20.
rash was worse on her neck and upper chest; it went down her waist and all over her back; a little bit  to her right arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash was worse on her neck and upper chest; it went down her waist and all over her back; a little bit  to her right arm) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced RASH (rash was worse on her neck and upper chest; it went down her waist and all over her back; a little bit  to her right arm). At the time of the report, RASH (rash was worse on her neck and upper chest; it went down her waist and all over her back; a little bit  to her right arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported. No treatment information was provided. Her HCP recommended she does not receive the 2nd dose.
Patient experienced chest tightness and slight shortness of breath.  She said the sensation was familiar from previous food allergies.  Administered EpiPen 0.3mg immediately, followed by a dose of chlorpheniramine 4mg. Patient reported feeling better almost instantly.  I phoned Dr, her allergist to report the event.  Dr wished to see her asap, and patient went to office.  Spoke to both patient and physician assistant today and patient is doing fine.  They are treating her with Prednisone and will follow up with patient on Friday.
By 1/6 eight days following the injection a bruise began to form under the skin near the site. It extended outward to a circumference of approx. 15 X 15 cm. it since has faded, employee saw physician yesterday for this and there is no treatment given. Advised to have shot # 2 against COVID by her doctor.
autoimmune hemolytic anemia; Evans Syndrome;  Jaundice (presumed from hemolysis) weakness light-headedness Patient received first COVID-19 Moderna vaccination ~10-14 days prior to onset of hospitalization.   Presented with weakness, malaise, jaundice.  Lab tests revealed severe anemia that did not respond to transfusions (presumed due to ongoing hemolysis).  Began treatment with corticosteroids (IV Solu-Medrol) and IV immunoglobulin to attempt to treat immune-mediated hemolysis.
Swollen face, flushed face, hives around face, neck, eyes, hands swollen and hives on fingers.
R deltoid area and arm red and swollen and fever, pt seen by Dr given Motrin and Tylenol. Pt given instructions to RTL if worse, fever increase mother took child to ED, admitted with antibiotics and released next day.
Breast swollen, red and hot to the touch. This is the area where I previously had radiation.   Area where lymph nodes were removed were sore and tender
Vaccine side effects. Receive ZOSTAVAX vaccination on 5/16/17 on the same day as Tdap (left arm). Both injection sites were tender that day but that was all that day. The next day the tetanus site was still tender but the shingles vaccine side started to swell and turn red and was warm. Swelling was an oval about 2" x 1" and stay that way for a week. On May 24 the swelling was down and the site was just tender but beginning to itch. On May 25 they started to have flulike symptoms: sore throat and diarrhea. The itching in food like symptoms continue today.
Within two hours, high fever, > 102, and extreme lethargy, swelling in both legs where vaccines were administered. Swelling went away by next day, fever persisted, spiking up to over 102 repeatedly. Patient was seen in Emergency room, two days later came down with (nosocomial) rotavirus, probably exposed in ER. Patient has still not recovered from rotavirus.
Five minutes at receiving Flu vaccine, employee c/o " L arm itching from deltoid to wrist." Given 25 mg of Benadryl and sent to the Emergency department.
After the second shot, the same severe back spasms that occurred after the first shot, came back overnight/early morning hours of Sept 26. This is lasting even now on Sept 29. The spasms were non-stop Sept 26 & 27 and have been intermittent Sept 28 & 29. I have never had muscle spasms like this before the shot. After I recovered from the first dose, the spasms stayed away, until I received my second dose of the COVID-19 vaccine.
Brain fog (severe, 3 months' duration) and eczema (itchy patch on trunk).
Was made aware of patient reaction 2/25/16. Patient says she had a fever and wasn't feeling good. She was admitted in hospital due to infection/reaction to vaccines.
p/vax c/o dizziness; nausea & fever & body aches; 2days later had cough; head congestion & T101.2; 6 days p/vax given all symptoms resolved
Vial was initially stored in the refrigerator on 2 Aug 2023 and administration of vaccine on 5 Sep 2023; No adverse event; Dose administered after 30-day Use By Date; Bivalent Booster for infant 6 month to 5-year-old yellow box pink or magenta cap with vial size 0.4 ml; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 2 Aug 2023 and administration of vaccine on 5 Sep 2023), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Bivalent Booster for infant 6 month to 5-year-old yellow box pink or magenta cap with vial size 0.4 ml) and NO ADVERSE EVENT (No adverse event) in a 22-month-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 05-Sep-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Sep-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Bivalent Booster for infant 6 month to 5-year-old yellow box pink or magenta cap with vial size 0.4 ml). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 2 Aug 2023 and administration of vaccine on 5 Sep 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 2 Aug 2023 and administration of vaccine on 5 Sep 2023), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Bivalent Booster for infant 6 month to 5-year-old yellow box pink or magenta cap with vial size 0.4 ml) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator on 2 Aug 2023 and administration of vaccine on 5 Sep 2023) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Bivalent Booster for infant 6 month to 5-year-old yellow box pink or magenta cap with vial size 0.4 ml).    Concomitant medication not reported.   It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Bivalent Booster for infant 6 month to 5-year-old yellow box pink or magenta cap.  Individual vials or intact cartons was 1 dose and vial size were 0.4ml The vial did not undergo any temperature excursions.  Treatment medication not reported.
Patient received 0.3ML dose but should have received 0.2ml dose for age group. Per CDC, dose doesn't have to be repeated.
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a 29 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A expiry: 21-SEP-2021) dose was not reported, administered on 24-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On 24-SEP-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious. This case, from the same reporter is linked to 20210958423, 20210958249, 20210958405, 20210958993, 20210958405, 20210958366, 20210958502 and 20210958716.
got the COVID virus after being fully vaccinated; got the COVID virus after being fully vaccinated; This is a spontaneous report from a contactable consumer or other non-health professional. A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of ad-ministration on an unspecified date as dose 1, single and received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient got the covid virus after being fully vaccinated. Reporter was concerned about the fact that he was hearing quite a few people wind up getting the virus even though they have been fully vaccinated with the COVID vaccine. Reporter cousin went into a assisted living facility 2 months ago, and she has been previously vaccinated. He has been fully vaccinated as well and three of the people got covid at her assisted living that have been fully vaccinated. He was wondering if Pfizer was started to get any more information about the virus and the vaccine. He knows the vaccine was not 100% effective and question was Pfizer getting an uptick in people that are getting the virus after vaccination. Reporter do not have information on the three people at the assisted living. Reporter was just concerned about himself and worried about some of the information out there not being accurate. Just like some places say no mask, and some say mask. He got vaccinated back in Mar2021. He do not know how much longer he has to live and would just like more information. The patient under-went lab tests and procedures which included covid-19: positive on unspecified date. The clinical out-come of events was unknown.  Information on the lot/batch number has been requested.
Recipient reports having an idiopathic autoimmune disorder where she can have random events where exposures can cause an increase in her histamine production resulting in rash and itching.  She denied history of any previous anaphylaxis.  She was advised prior to the start of the clinic to follow up with her allergist to discuss risk v. benefit of the vaccine with her condition.  On the date of the clinic she reports that she consulted her allergist who encouraged her to accept the vaccine but be monitored for 30 minutes.  Approximately 10 minutes after receiving the vaccine the injection site reddened, felt hot to the recipient, and was itchy.  She reported the itching spread to her scalp.  She verbalized this is a typical reaction that she has and that it can self resolve or improves with benadryl.  It was at his time that she reported she had taken benadyl 25 mg approximately 1 hour prior to vaccination.  The reaction did no spread beyond her injection site and scalp itching resolved quickly.  She verbalized symptom relief with a cold pack and was under observation for 45 minutes at which time the redness decreased.  She verbalized that she felt safe to leave the clinic, vital signs were stable and no signs of reaction progression or anaphylaxis.  She was instructed to notify her allergist and to call 911 if symptoms worsened, as well as to notify the Primary vaccine coordinator when able to for any further issues and updates.  By 1330 she called and reported she was fully back to baseline and that she was instructed by her allergist to take prednisone and that she had also taken another benadryl once she got home.  She reports the allergist called it a mild reaction and "was not concerned".
Fever 103, wheezing, local erythema at (L) arm, myalgia.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 30-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported   No treatment information was provided  All patients were monitored for at least 15 minutes after the injection with no adverse events reported.    This case was linked to MOD-2021-403245 (Patient Link).
Donor stated she felt weakness at approximately 1900 on 03/18/08 at approximately midnight of the same day she stated she vomited and felt fine afterward.
In OCt90 10 out of 59 pts were found to have insuff or neg antibody levels during post serology testing for anti HBs.  (see EBU910168 - EBU910175 - EBU910177)
devel itchy red hives some hr p/vax occurred mostly on face;some on arms & trunk;resolved over 3 days no tx (had ppd skin test 9OCT96);
This spontaneous report as received from a Bachelor Science Nurse refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated once with a 0.65 ml dose of ZOSTAVAX. Route and lot n number were not provided. No other co-suspects were reported. No concomitant medications were reported. On an unknown date, the patient experienced an inflammatory reaction at the injection site. No rash was reported. the patient sought medical attention. No treatment information was reported. The outcome of quite an inflammatory reaction at the injection site was unknown. The relatedness for quite an inflammatory reaction at the injection site was unknown for ZOSTAVAX. Additional information has been requested.
A mother reported that her 26 month old son received his 1st dose of Prevnar in 10/00. Two weeks, post vax, he developed a high fever, abdominal gas, diarrhea and vomiting. The symptoms lasted 5 days. The reporter noted that the physician stated "this was flu, not related to Prevnar". Antibodies were checked 3 weeks, post vax, and reportedly, no antibody response was noted. The child has a history of ear and upper respiratory tract infections since he was 5 months old. Allergies have been ruled out by a blood test. Common variable Immune Deficiency Syndrome has been ruled out. IgA antibody tests were negative.
I had increased shoulder and neck pain and then began to have lesions on the upper arm and back of the shoulder that have progressed into the anterior arm and forearm down to the wrist. Pustular vesicles and other characteristics of shingles but over several dermatomes and I am having hyperestesia on the right side of the head from midline over, the right side of the face and right chest that feels like a mild sunburn.  I also have a single lesion on the left upper arm.
hemiplegic migraine, blurry vision, slurred speech, high bp 140/103,  l
Patient was administered dose of pediatric Pfizer vaccine as booster for adult series.    Was given correct pfizer booster after initial error